Skip to main content

stock

PTIX · Protagenic Therapeutics, Inc.\new

What Protagenic Therapeutics, Inc.\new reports to the SEC, read from its filings.

Open in the app

Price

The live PTIX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PTIX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
1,810,208 as of 2026-08-19 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
316.9%
ROA
195.3%

Health

Current ratio
0.7x
Debt/equity
—

Deep value

NCAV
-$362,743
NCAV per share
-$0.20
Price/NCAV
Locked
NNWC
-$506,629
NNWC per share
-$0.28
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$961,247-$963,616
10-Q filed 2026-08-19
2026-03-31——Gross profit: unreported by this company.-$1.26M$5.08M
10-K filed 2026-08-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-12-31——Gross profit: unreported by this company.-$925,103$2.21M
10-Q filed 2026-03-09
2025-09-30——Gross profit: unreported by this company.-$1.11M-$869,496
10-Q filed 2026-03-09
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30$0—Gross profit: unreported by this company.-$1.21M-$5.06M
10-Q filed 2026-08-19
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$0—Gross profit: unreported by this company.-$1.45M-$1.44M
10-Q filed 2025-05-13
2024-12-31$0—Gross profit: unreported by this company.-$401,401-$850,287
10-Q filed 2026-03-09
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$355,374-$582,387
10-Q filed 2026-03-09
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$2.80M
Equity
$1.72M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-03-31$0-$4.50M$1.37M—
2025-03-31$0-$2.59M-$3.59M—
2024-12-31$0-$5.70M-$5.53M—
2023-12-31$0-$4.53M-$5.00M—
2022-12-31$0-$3.56M-$3.56M—
2021-12-31$0-$4.14M-$4.52M—
2020-12-31$0-$2.55M-$2.55M—
2019-12-31—-$2.09M-$1.75M—
2018-12-31—-$2.31M-$2.56M—
2017-12-31—-$2.37M-$2.26M—

Company filings

1 offering filing in 12 months · since Fri Oct 24

events

  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Aug 208-K
  • Executive or director change

    Executive or director change
    Apr 68-K
  • Executive or director change

    Executive or director change
    Mar 28-K
  • Material agreement, Agreement ended, Acquisition or sale completed, Unregistered share sale, Other event

    Material agreementAgreement endedAcquisition or sale completedUnregistered share saleOther event
    Feb 238-K
  • Listing standard notice

    Listing standard notice
    Jan 58-K
  • Listing standard notice, Regulation FD disclosure

    Listing standard noticeRegulation FD disclosure
    11/26/20258-K

Insiders, politicians and funds

Insider trades, last 90 days

  • ARMEN GARO H

    EXEC. CHAIR & PRINCIPAL OFF, Director

    Buy$13,000

    Aug 24, 1:20 PM ET

  • ARMEN GARO H

    EXEC. CHAIR & PRINCIPAL OFF, Director

    Buy$9,811

    Aug 20, 8:20 PM ET

  • ARMEN GARO H

    EXEC. CHAIR & PRINCIPAL OFF, Director

    Buy$945

    Aug 20, 9:23 AM ET

  • ARMEN GARO H

    EXEC. CHAIR & PRINCIPAL OFF, Director

    Buy$710

    Aug 12, 6:51 PM ET

  • ARMEN GARO H

    EXEC. CHAIR & PRINCIPAL OFF, Director

    Buy$151

    Aug 10, 10:17 AM ET

All insider trades for PTIX

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named PTIX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about PTIX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about PTIX.

nakagai

Signals on PTIX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PTIX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Protagenic Therapeutics, Inc.\new (PTIX): SEC filings, financials and insider trades · Nakagai